PerioPatch Receives Excellent Market Reviews

April 21, 2013

Izun Pharmaceuticals is proud to announce that PerioPatch was reviewed by Dr. Gordon Christensen’s Clinical Research Group. The patch was independently reviewed by selected research clinicians in a dental office environment by testing on their own patients.

PerioPatch-Box-izunpharmaThe clinicians were requested to assess efficacy and functionality in a clinical office setting, and patient response, as part of the evaluation.

PerioPatch received very high grades by the clinician reviewers, with 80% of the evaluators recommending incorporation of PerioPatch into routine dental care for treating Periodontitis and Gingivitis. This is reflective of the general response we have seen from the constantly increasing number of dentists who have incorporated PerioPatch into their everyday practice.